CS
SBBP

Credit Suisse’s Strongbridge Biopharma plc. SBBP Stock Holding History

Credit Suisse’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-12,408
Closed -$30K – 4682
2020
Q4 		$30K Buy
+12,408
New +$29.9K ﹤0.01% 4286
2019
Q2 		– Sell
-25,331
Closed -$126K – 4287
2019
Q1 		$126K Buy
+25,331
New +$125K ﹤0.01% 3827
2018
Q2 		– Sell
-12,681
Closed -$112K – 4215
2018
Q1 		$112K Buy
+12,681
New +$94.9K ﹤0.01% 3787
2017
Q4 		– Sell
-14,375
Closed -$99K – 4283
2017
Q3 		$99K Buy
+14,375
New +$99.2K ﹤0.01% 4093

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Credit Suisse's SBBP Position: Q1 2021 in Review

Credit Suisse sold out of Strongbridge Biopharma plc. (SBBP) in Q1 2021, closing a stake of 12,408 shares — an estimated $30K sold.

Credit Suisse first reported a position in SBBP in Q3 2017 and held it in 4 quarters. The position peaked at $126K in Q1 2019. 74 funds tracked by Wall St. Rank hold SBBP as of Q1 2021.

  • Credit Suisse reported no remaining Strongbridge Biopharma plc. position as of Q1 2021 after selling out during the quarter.
  • Credit Suisse sold 12,408 Strongbridge Biopharma plc. shares in Q1 2021, an estimated $30K.
  • Credit Suisse first reported a position in Strongbridge Biopharma plc. in Q3 2017 and held it in 4 quarters.
  • Credit Suisse's Strongbridge Biopharma plc. position peaked at $126K in Q1 2019.
  • 74 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q1 2021.

Based on Credit Suisse's 13F filing for Q1 2021, filed 14 May 2021.